featured
Lawmakers In Two Red States Hold Hearings On Psychedelic Therapy’s Potential To Combat The Opioid Epidemic

Published
2 weeks agoon

Lawmakers in two GOP-controlled state legislatures hosted discussions on the potential of the psychedelic ibogaine to treat addiction and other mental health conditions this week.
In Mississippi, the House Public Health and Human Services and Senate Public Health and Welfare held a three-hour joint hearing at which lawmakers heard from military veterans, scientific researchers and advocates on ibogaine’s therapeutic promise.
In Kentucky, the legislature’s Interim Joint Committee Health Services examined ibogaine as a potential way to treat opioid dependency as part of a broader hearing that also touched on other topics.
Rep. Sam Creekmore (R), who chairs the Mississippi House panel that cohosted the hearing in his state, said that “entire communities, have been scarred, families shattered, and too many lives cut short” by the opioid epidemic.
“On top of that, we face a growing mental health crisis that weighs heavily on our veterans, first responders and trauma survivors. We know the truth that current treatments, while essential, are not enough for everyone,” he said at the Thursday hearing. “Our responsibility as policymakers is not to embrace new solutions blindly, but neither can we turn our away from credible science, or from testimony from those who found hope where hope seemed lost.”
Creekmore, who recently authored an op-ed for Marijuana Moment about ibogaine, previously said the hearing was meant to help inform legislation he’s planning to introduce legislation, which he said is largely modeled after a bill that passed the Texas legislature and was signed into law in June.
That measure will create a state-backed research consortium to conduct clinical trials on ibogaine as a possible treatment for substance use disorders and other mental health conditions. The ultimate goal of the project is to develop the psychedelic into a prescription drug with U.S. Food and Drug Administration (FDA) approval.
Americans for Ibogaine CEO Bryan Hubbard told Mississippi lawmakers at the hearing that the “the objective here is to develop ibogaine as expeditiously and efficiently as possible through the creation of a single unified FDA trial that will involve multiple states across the country.”
Creekmore wants Mississippi to allocate $5 million to support the effort to conduct trials on ibogaine.
Thomas Recore, director of the state Department of Mental Health Medical Director, also spoke at the hearing, telling lawmakers that it is “clear” that ibogaine has enough potential to justify further studies.
Meanwhile, in Kentucky, lawmakers on Wednesday heard a presentation from a GOP senator who wants to invest state resources into research on ibogaine’s potential to address opioid addiction and other mental health issues.
Sen. Donald Douglas (R), who is also a doctor, said the current clinical treatment model that has been used “for decades” just “ain’t working.”
He told colleagues he plans to file legislature during the next session modeled on the new Texas ibogaine research funding law, noting that he’s part of a consortium of lawmakers from about 15 other states who are coordinating on the issue, The Lexington Herald-Leader reported.
In 2023, Kentucky officials had considered a plan to use $42 million from Kentucky’s opioid settlement fund for psychedelics research. But the effort, spearheaded at the time by Hubbard of Americans for Ibogaine when he served as chair of the Kentucky Opioid Commission, fell apart after he was replaced by a newly elected state attorney general.
Gov. Andy Beshear (D) on Thursday urged caution about ibogaine, saying “it can cause really significant reactions” and that “a lot more research needs to be done” on the psychedelic.
“You don’t tread lightly into something that can be that powerful or potentially be that damaging. This is what the FDA is for, this is what they ought to be researching,” he said, according to the Herald-Leader. “Let’s make sure that we’re not just looking at the next bright, shiny object, but that we’re recognizing the hard work with the structure we have in place, [which] has done so much to help our people.”
Meanwhile, at the federal level, a GOP senator recently said he’s “confident” that, under the Trump administration, lawmakers will help secure alternative treatment options for military veterans—including access to psychedelic medicine.
The head of the Department of Veterans Affairs (VA), Doug Collins, recently touted his role in promoting psychedelics access for veterans with serious mental health conditions, saying he “opened that door probably wider than most ever thought” was possible.
Collins, who raised the issue in a Cabinet meeting with the president, said “we’re going to do it the right way,” while advancing clinical trials investigating ibogaine, MDMA and psilocybin.
Last month, the secretary also reiterated that he’s “very open” to expanding access to psychedelics therapy for veterans—emphasizing that he’s intent on finding ways to “cure” people with serious mental health conditions and not just treat their surface-level symptoms.
Collins noted that VA either internally or through private partnerships is actively conducting about a dozen clinical trials into “various different substances that we’re seeing actually really good results on,” including one based at VA Bronx Health Care that’s investigating MDMA-assisted therapy with “actually really, really good results.”
During that interview, Collins was also shown a recent clip of Navy SEAL veteran Rob O’Neill, who killed Osama Bin Laden, talking about his theory that the federal government has intentionally avoided providing access to psychedelic medicine because cures are less profitable than long-term treatments. Collins responded by saying, “I’m going to tell you right now: This secretary of veterans affairs, myself, I want to heal people.”
Meanwhile, last month a GOP-controlled House committee approved an amendment attached to a must-pass defense bill that would require a “progress report” on an ongoing psychedelic therapy pilot program for active duty military service members and veterans.
Separately, bipartisan congressional lawmakers recently met with the VA secretary to discuss pathways to provide access to psychedelic medicine as an alternative treatment option for conditions such as PTSD.
After requesting the meeting with Collins in May, Reps. Lou Correa (D-CA) and Jack Bergman (R-MI)—founding co-chairs of the Congressional Psychedelic Advancing Therapies (PATH) Caucus—said the three had a productive conversations about advancing psychedelics therapy for the veteran community.
Collins has stood out as a VA secretary who’s especially passionate about exploring the potential of substances such as ibogaine and MDMA to provide relief from serious mental health conditions, coordinating with other officials including Robert F. Kennedy Jr., the head of HHS, who said recently that his aim is to free up plant-based medicine options within 12 months.
Former U.S. House Speaker Newt Gingrich (R-GA) separately said the psychedelic ibogaine represents an “astonishing breakthrough” in the nation’s current “sick care system” that’s left people with serious mental health conditions without access to promising alternative treatment options—and he intends to use his influence to advance the issue.
Also, the House recently included an amendment to a spending bill from Correa and Bergman that would encourage VA to support research into the benefits of psychedelics in treating medical conditions commonly affecting military veterans.
The lawmakers separately introduced a bill in April to provide $30 million in funding annually to establish psychedelics-focused “centers for excellence” at VA facilities, where veterans could receive novel treatment involving substances like psilocybin, MDMA and ibogaine.
Collins, for his part, also disclosed in April that he had an “eye-opening” talk with Kennedy about the therapeutic potential of psychedelic medicine. And he said he’s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access.
Bergman has also expressed optimism about the prospects of advancing psychedelics reform under Trump, arguing that the administration’s efforts to cut spending and the federal workforce will give agencies “spines” to tackle such complex issues.
Kennedy, for his part, also said in April that he had a “wonderful experience” with LSD at 15 years old, which he took because he thought he’d be able to see dinosaurs, as portrayed in a comic book he was a fan of.
Last October, Kennedy specifically criticized FDA under the prior administration over the agency’s “suppression of psychedelics” and a laundry list of other issues that he said amounted to a “war on public health” that would end under the Trump administration.
In December, VA separately announced that it’s providing $1.5 million in funding to study the efficacy of MDMA-assisted therapy for veterans with PTSD and alcohol use disorder (AUD).
Photo courtesy of Flickr/Scamperdale.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
You may like
-
Six hurt in shooting at marijuana event in SF's Bayview
-
Kentucky Medical Marijuana Dispensaries Should Be Stocked With Products Ready For Sale By Next Month, Top State Official Says
-
Deputies: 3,500 child sex abuse images, marijuana grow operation found in NC home raid
-
Regulators Ready to Enforce Cannabis Laws on Hemp THC Retailers in Maryland
-
California reaps over $250 million from 2nd Quarter cannabis sales
-
Meet the World’s First Cannabis Rugby Team: Crewmen 7’s Tackle Stigma Head-On
featured
Kentucky Medical Marijuana Dispensaries Should Be Stocked With Products Ready For Sale By Next Month, Top State Official Says

Published
57 minutes agoon
September 15, 2025
Kentucky’s top medical marijuana regulator said he expects that dispensary shelves will be stocked with products ready for sale to patients by next month.
Two of the state’s 16 medical cannabis cultivators are now operational, according to Cannon Armstrong, executive director of Kentucky’s Office of Medical Cannabis (OMC).
“If everything goes according to plan for them, I think that they’ll have medical cannabis that will be ready to harvest and be put on the shelf, you know, by October,” he told Spectrum News 1. “So we’re moving and we’re finally getting to a point where we’re, these patients are going to receive this medication sooner than later.”
Armstrong predicted that the first sales will likely occur at a dispensary in Beaver Dam called The Post.
“I think you’re going to see the first products out there based upon just how it’s shaken out,” he said. “You know, someone may step up their timeline and may get out there before that or get product from there and place it somewhere else in the state.”
As of now, OMC has approved more than 19,000 patients certifications, Armstrong said.
He added that medical cannabis supplies should be relatively scarce as the market first launches, and said that as a result initial prices will be higher than they eventually will be.
Earlier this month, Gov. Andy Beshear (D) said he thought medical marijuana would be available to Kentucky patients by the end of 2025.
“The medical marijuana program is moving forward,” he said at a press briefing at the time.
“I think most of our dispensaries now have their home address [and] are set about where they’re going to be, but [for] some of the inspections that have to happen in dispensaries, they have to have product that’s there,” he said. “So I do believe they’ll be operating before the end of the year.”
Those comments came roughly a month after the governor announced that the state’s first medical cannabis dispensary has officially been approved for operations, calling it “another step forward as we work to ensure Kentuckians with serious medical conditions have access to the medicine they need and deserve.
He previously touted an earlier “milestone” in the state’s forthcoming medical marijuana program, with a licensed cultivator producing “the first medical cannabis inventory in Kentucky history.”
Beshear’s office has said that other cannabis licensees, including processors and testing labs, are expected to become operational soon.
In July, Beshear sent a letter to President Donald Trump, urging him to reject congressional spending bill provisions that would prevent the Justice Department from rescheduling marijuana.
In the letter to the president, he emphasized that a pending proposal to move cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) is something “you supported in your presidential campaign.”
“That process should be allowed to play out. Americans deserve leadership that won’t move the goalposts on them in the middle of the game,” Beshear said, noting that he was among the tens of thousands who submitted public comments in favor of the reform after it was initiated under the Biden administration, “demonstrating broad public interest in rescheduling.”
“I joined that effort because this is about helping people. Rescheduling would provide suffering patients the relief they need,” the governor said. “It would ensure communities are safer—because legal medical products reduce the illicit market. It would provide new, meaningful research on health benefits.”
Beshear also mentioned a letter to DEA he signed onto last year urging rescheduling, “because the jury is no longer out on marijuana. It has medical benefits.”
Back on the state level, the governor recently said he acknowledges that “it’s taken longer than we would have liked” to stand up the industry since he signed medical marijuana legalization into law in 2023.
In recognition of that delayed implementation, he recently signed an executive order to waive renewal fees for patients who get their cards this year so that they don’t get charged again before retailers open. And another order he signed providing protections for qualified patients who obtain medical marijuana outside of Kentucky “will stay in place.”
Beshear separately announced in May that the state has launched a new online directory that lets people see where medical cannabis dispensaries will be opening near them.
He emphasized that the state has been working to deliver access to patients “at the earliest possible date,” and that involved expediting the licensing process. The governor in January also ceremonially awarded the commonwealth’s first medical marijuana cards.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
Meanwhile, the governor sent a letter to Kentucky’s congressional delegation in January, “urging them to take decisive action to protect the constitutional rights of our law abiding medical cannabis patients” by repealing the federal ban on gun possession by people who use marijuana.
That came after bipartisan Kentucky senators filed legislation that similarly called on the state’s federal representatives to take corrective action, which Beshear said he supports but would like to see even more sweeping change on the federal level.
The federal Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) warned Kentucky residents late last year that, if they choose to participate in the state’s medical marijuana program, they will be prohibited from buying or possessing firearms under federal law.
As far as the implementation of the state’s medical cannabis law goes, Beshear said in his State of the Commonwealth address in January that patients will have access to cannabis sometime “this year.” He also later shared tips for patients to find a doctor and get registered to participate in the cannabis program.
Health practitioners have been able to start assessing patients for recommendations since the beginning of December.
While there currently aren’t any up-and-running dispensaries available to patients, Beshear has further affirmed that an executive order he signed in 2023 will stay in effect in the interim, protecting patients who possess medical cannabis purchased at out-of-state licensed retailers.
During last year’s November election, Kentucky also saw more than 100 cities and counties approve local ordinances to allow medical cannabis businesses in their jurisdictions. The governor said the election results demonstrate that “the jury is no longer out” on the issue that is clearly supported by voters across partisan and geographical lines.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Regulators Ready to Enforce Cannabis Laws on Hemp THC Retailers in Maryland

Published
2 hours agoon
September 15, 2025
Cannabis regulators in Maryland are ready to bring the force of the law against businesses selling intoxicating products with hemp derivatives after an appellate court ruled in favor of the state last week.
The Maryland Alcohol, Tobacco and Cannabis Commission (ATCC) issued a warning on Sept. 12 that was directed at businesses selling intoxicating THC products without a cannabis license, putting them on notice of the appellate court’s order.
In particular, the Appellate Court of Maryland ruled on Sept. 9 that the state’s law prohibiting businesses from selling hemp-derived products without a license is constitutional, reversing the Washington County Circuit Court’s decision to grant a preliminary injunction from October 2023.
The injunction protected hemp retailers, producers, farmers and consumers, who had challenged the state’s licensing requirement under Maryland’s Cannabis Reform Act (CRA), legislation enacted in July 2023 to regulate an adult-use cannabis market. The injunction had prevented the ATCC from enforcing the cannabis law against businesses selling hemp-derived THC products without a cannabis license for nearly two years.
“All retail establishments engaged in the sale of intoxicating THC, especially those in business prior to July 1, 2023, are on notice that the appellate court’s order, when effective, will terminate the limited protection afforded to them by the preliminary injunction issued by the Washington County Circuit Court,” according to an ATCC notice, warning businesses of its forthcoming enforcement efforts.
“Moving forward, any person or business that engages in the distribution or sale of an intoxicating THC product without the required license issued to them by the Maryland Cannabis Administration (MCA) is subject to criminal prosecution under Maryland law,” according to the notice.
In addition to the ATCC’s restored enforcement powers, the appellate court ruled that intoxicating products containing synthetic hemp derivatives created in a chemical process, such as delta-8 and delta-10 THC, “are now and have always been illegal in Maryland.”
The ATCC provided a list of criminal offenses and violations for the distribution or sale of an intoxicating THC product without a license by the MCA:
- Packaging, Labeling and Potency Violations: Selling a product that violates THC product packaging, labeling and potency standards – ABCA § 36-1104(b)
- False or Illegal THC Advertising: Advertising a product as containing an amount of THC that violates AB § 36-1102 – ABCA § 36-1104(c)(1)
- Unlicensed Sales Above THC Limits: Selling a product that contains more than 0.5 milligrams of THC per serving or 2.5 milligrams of THC per package without a license from the MCA – ABCA § 36-1102(b)(1)
- Synthetic Intoxicating THC Products: Selling or distributing a cannabinoid product that is not derived from naturally occurring biologically active chemical constituents (aka “synthetic intoxicating THC products”) – ABCA § 36-1102(c)
According to the ATCC, the commission has the authority to seize products on sight that violate the Alcoholic Beverages and Cannabis Articles (ABCA) listed above.
Convictions related to the ABCA could result in $5,000 fines for each offense, including up to $10,000 for offenses of selling or distributing synthetic THC products. If convicted, the seized products can be destroyed, according to the ATCC.
“In response to the appellate court’s decision, the ATCC is prepared to expand its state-wide investigation and enforcement actions against any persons and businesses who distribute or sell intoxicating THC products in violation of Maryland law,” according to the notice. “The ATCC continues to be committed to ensuring the public health and safety of Marylanders through the application and enforcement of Maryland’s cannabis laws.”

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Meet the World’s First Cannabis Rugby Team: Crewmen 7’s Tackle Stigma Head-On

Published
3 hours agoon
September 15, 2025
Picture this: a rugby pitch, sweat in the air, bodies colliding with that mix of grace and chaos only rugby can deliver. On the sideline, instead of the usual beer logos and corporate banners, you see RAW Rolling Papers. Instead of Budweiser, there’s Beneleaves. Instead of a cooler stacked with light beer, there are capsules packed with CBD, CBG, and electrolytes.
Welcome to the world of Crewmen Rugby 7’s, the first cannabis-backed rugby squad in the United States. Born from a half-serious Instagram experiment and fueled by plant-based sponsorships, the Crewmen are rewriting what sports sponsorship looks like, and clearly enjoying the ride.

From a DM to a Movement
When Nigel Bowman launched the Crewmen, there was no big plan. No investors. No strategy deck. Just a phone, an idea, and an Instagram post.
“Crewmen Rugby 7’s is the first Cannabis Advocacy athletic organization in the United States. We strive to break the stigma between high-performance athletics and cannabis culture. I literally began this team on Instagram just to generate interest from local players for a small tournament. It caught wildfire and took off,” he told High Times.

That wildfire turned into a traveling squad of athletes who now compete in sevens tournaments, welcome players from around the world, and run onto the pitch wearing cannabis-branded kits.
RAW on the Jersey, Respect on the Pitch
If you know cannabis culture, you know RAW. Seeing the logo stamped on a rugby jersey is both a surprise and a statement. It says the old rules are changing.
“Crewmen Rugby is sponsored by amazing brands such as RAW Rolling Papers. Rugby is known for its hard game play and camaraderie,” Bowman said. “We wanted to change the dynamic of Alcohol Sponsorship to Cannabis Sponsorship in the aspect of promoting recovery and wellness. Our amazing sponsors help support the team with covering necessary tour expenses like housing, flights and uniforms. I keep great rapport with sponsors that have helped build us up.”

That partnership didn’t happen overnight. “All of our sponsorships were derived from the Instagram platform and direct messages to the companies. It took about a year and a half to gain sponsorship from RAW. It was well worth the wait to represent such an iconic brand within cannabis culture!”
The takeaway is clear: rugby doesn’t need beer logos to thrive. Cannabis brands can carry the culture too.
Recovery Is Part of the Game
The Crewmen aren’t just about uniforms. They’re leaning into recovery, showing that cannabinoids can help athletes keep going after the toughest hits.
“We have a line of custom-formulated hemp products from our vertical processor, Reverb Wellness, under Crewmen Brands. Some of these products include a topical 3:1 CBD to THC, rosin disposable vapes, recovery capsules with CBD:CBG:Electrolytes and pre-rolls. We also have a line of .510 thread cartridges processed by Beneleaves Limited for Medical and Recreational use in dispensaries around Ohio.”
For Bowman, the products double as proof that cannabis has a place in sports medicine and athlete care.
Stigma, Smashes, and Selling Jerseys
Rugby fields are usually a parade of beer and liquor logos. Cannabis logos, though? They still make people stop and stare. That’s exactly the point.
“Sports and athletics have stigmatized the use of cannabis for as long as I can remember. I started the Crewmen with the idea of putting well-known Cannabis brands in the face of the Rugby community. Athletes use cannabis or CBD to recover from intense workouts/games and I’d like to normalize it within the sports community.”
The reaction has been instant. “Being able to host international athletes is a true privilege. When we wear our uniforms to large-scale tournaments, people always want to buy one. I believe that it’s because they have never seen it before, as alcohol sponsors flood our Rugby Community. We just wanted to separate ourselves from the norm. We still maintain the high-performance aspect of the sport. While wearing the brands that have made a major impact on the Cannabis Community.”
Eyes on Rugbytown
Every team has a dream stage. For the Crewmen, it’s Rugbytown USA in Glendale, Colorado, one of the most prestigious sevens tournaments in the country.
“What would be next for Crewmen Rugby 7’s is ideally to make it to Rugbytown USA. That is the largest-streamed International 7’s competition in the United States. I’m hopeful that 2026 is our year. In previous years, Native Roots dispensary sponsored the Tournament based in Glendale, Colorado. So the rugby community isn’t unfamiliar with cannabis sponsors. But it’s more hush-hush than the narrative that we push with Crewmen Rugby 7’s.”
If a Team Were a Strain
Ask Bowman what strain captures his team, and he doesn’t miss a beat.

“If Crewmen had a signature strain, it would probably be in the Kush lineage. Kush has a wide array of crosses and I believe we showcase individuality while maintaining a common goal. I think we highlight the products under Crewmen Brands by Reverb Wellness very well. They have started to gain popularity nationwide. Even getting our topical to the Rugby Tens Championship in California and Rugbytown for international athletes to use for recovery. Our team is about educating people and players who are not informed about how Cannabis can improve overall health and quality of recovery.”
Shock, Curiosity, Amazement
Face the Crewmen on the field and it’s not just the rugby that gets people talking.
“The reaction that first comes across from our opponents and other spectators is amazement. It’s something a lot of players and staff haven’t seen before we brought Cannabis Sponsors to the table. Now more and more teams are diversifying their sponsors. I’d like to think that cannabis sponsorship will be a normal thing for all athletic associations within the coming years.”
A Gentleman’s Game Played by Hooligans
Bowman says it best: “Rugby is a very high-impact sport. A Gentleman’s Game Played By Hooligans, if you will. Cannabis Culture adds to the team’s identity by spreading education about the plant we are so passionate about. If it weren’t for a wacky idea to start a cannabis sports team one day when I was budtending, we wouldn’t exist. Chase your dream no matter how wacky people may think it is. There’s always at least one person willing to back your cause.”
What started as a shot in the dark is now a traveling crew with a mission. The Crewmen keep playing, keep teaching, and keep proving that the best culture is the one lived out loud.
Photos courtesy of Crewmen Rugby 7.

Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.

Six hurt in shooting at marijuana event in SF's Bayview

Kentucky Medical Marijuana Dispensaries Should Be Stocked With Products Ready For Sale By Next Month, Top State Official Says

Deputies: 3,500 child sex abuse images, marijuana grow operation found in NC home raid

Regulators Ready to Enforce Cannabis Laws on Hemp THC Retailers in Maryland

California reaps over $250 million from 2nd Quarter cannabis sales

Meet the World’s First Cannabis Rugby Team: Crewmen 7’s Tackle Stigma Head-On

Texas Supreme Court Refuses To Take Up Marijuana Case Challenging State’s Rejection Of Local Decriminalization Law

California Passes Bill to Ban Intoxicating Hemp Products Outside Cannabis Market

Pending Federal Hemp Legislation Could Reshape The Legal Industry By Banning Some Products (Op-Ed)

Verano Proposes to Redomicile Parent Company From British Columbia to Nevada

8,000 cannabis plants seized from illegal Bradford grow-op

New York Lawmakers Schedule Psychedelics-Focused Hearing To Discuss ‘Medicinal Value And Risks’ Of Psilocybin

Curaleaf Opens Cannabis Dispensaries in Florida, Ohio

How to Protect Your Outdoor Cannabis Crops From Pests

Feds provide anti-cannabis group a platform to bash legalization (Newsletter: September 15, 2025)

Dozen arrested after south Mississippi bust for illegal sales to underage customers

The Toking Traveler: Why Amsterdam Weed Is Mostly Boof

Arkansas Medical Marijuana Sales Are On Track To Set A New Annual Record

When Cannabis Brands Blur Into Youth Culture, Regulators Notice: Lessons From Tobacco’s Past

Rhode Island Marijuana Dispensary License Application Process Officially Launches

Middle school student found with cannabis in bookbag, Charles County deputies say

Smugglers who brought drugs on an industrial scale into Wales jailed

Attorney pulls out bag of cannabis in NC Supreme Court hearing

WHO AM I? Man wanted for New Bern cannabis store theft

Alert: Department of Cannabis Control updates data dashboards with full data for 2023

Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!

5 best CBD creams of 2024 by Leafly

EU initiative begins bid to open access to psychedelic therapies

New Study Analyzes the Effects of THCV, CBD on Weight Loss

Free delta-9 gummies from Bay Smokes

Discover New York’s dankest cannabis brands [September 2024]

5 best autoflower seed banks of 2024 by Leafly

Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

May 2024 Leafly HighLight: Pink Runtz strain

Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT

Recreational cannabis on ballot for third time in South Dakota

5 best THC drinks of 2024 by Leafly

Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News

Mississippi city official pleads guilty to selling fake CBD products

6 best CBD gummies of 2024 by Leafly

Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”

The Daily Hit: October 2, 2024

5 best delta-9 THC gummies of 2024 by Leafly

Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline

PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana

5 best THCA flower of 2024 by Leafly

People In This State Googled ‘Medical Marijuana’ The Most, Study Shows
Trending
-
California Cannabis Updates1 year ago
Alert: Department of Cannabis Control updates data dashboards with full data for 2023
-
Breaking News1 year ago
Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
-
best list1 year ago
5 best CBD creams of 2024 by Leafly
-
Business12 months ago
EU initiative begins bid to open access to psychedelic therapies
-
cbd1 year ago
New Study Analyzes the Effects of THCV, CBD on Weight Loss
-
Bay Smokes1 year ago
Free delta-9 gummies from Bay Smokes
-
autoflower seeds12 months ago
5 best autoflower seed banks of 2024 by Leafly
-
cannabis brands12 months ago
Discover New York’s dankest cannabis brands [September 2024]